Shanghai, China

Lei Wu

This inventor holds 3 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Regor Pharmaceuticals, Inc., Dana-Farber-Cancer Institute Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Wu. Retrieved from https://idiyas.com/inventor/lei-wu-oblksqqh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lei Wu - Innovator in Protein Degradation

Introduction

Lei Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of protein degradation, focusing on innovative compounds and methods that target specific proteins associated with various disorders.

Latest Patents

Lei Wu holds a patent for "Compounds, compositions, and methods for protein degradation." This patent discloses compounds that specifically target SMARCA2 and SMARCA4, leading to their degradation. The compositions and methods outlined in the patent are aimed at treating associated disorders and diseases, showcasing Wu's commitment to advancing medical science.

Career Highlights

Throughout his career, Lei Wu has worked with notable organizations, including the Dana-Farber Cancer Institute and Mann+Hummel GmbH. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Lei Wu has collaborated with Jun Qi, a fellow researcher, to further explore the implications of his work in protein degradation. Their partnership highlights the importance of teamwork in scientific innovation.

Conclusion

In summary, Lei Wu is an influential inventor whose work in protein degradation has the potential to impact the treatment of various diseases. His innovative approach and dedication to research continue to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…